MLAB Mesa Laboratories, Inc.

133.41USD-3.19%Mkt Cap: 749.83M USDP/E: 115.01

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilizatio…

Institutional holders20 on file

Key Statistics

Company
Market Cap749.83M USD
Enterprise Value900.12M USD
Revenue (TTM)251.32M USD
Gross Profit158.27M USD
Net Income (TTM)6.71M USD
Revenue/Share45.04 USD
Last Price133.41 USD
Fiscal Year EndMar 2026
MR QuarterSep 2026
Employees717
CountryUS
SectorTechnology
IndustryScientific & Technical Instruments
ISIN—
Valuation
P/E (Trailing)115.01
P/E (Forward)10.96
PEG—
EV/EBITDA18.44
EV/Revenue3.58
P/S2.98
P/B3.85
EPS (TTM)1.16 USD
EPS (Forward)12.17 USD
52W Range
69.5185% of range144.35
52W High144.35 USD
52W Low69.51 USD
Profitability
Gross Margin63.53%
Oper. Margin10.40%
EBITDA Margin19.42%
Profit Margin2.69%
ROE3.60%
ROA1.57%
ROIC3.29%
ROCE5.06%
Growth
Revenue Growth2.60%
Earnings Growth67.00%
Cash Flow & Leverage
Operating CF42.83M USD
CapEx (TTM)3.25M USD
FCF Margin20.53%
FCF Yield6.88%
Net Debt125.56M USD
Net Debt/EBITDA2.57
Net Debt/FCF2.43
Balance Sheet
Debt/Equity0.83
Current Ratio1.91
Quick Ratio1.23
Book Value/Sh34.66 USD
Cash/Share4.26 USD
Dividends
Fwd Div Rate0.64 USD
Trail. Div Rate0.64 USD
Div. Yield0.46%
5Y Avg Yield0.47%
Payout Ratio55.17%
Ex-Div DateNov 30, 2026
Pay DateDec 15, 2026
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)150.00 USD
Upside (mean)+12.4%
Target Range150.00 USD – 150.00 USD
# Analysts1
Ownership
Shares Out.5.62M
Float4.97M
Insiders5.57%
Institutions104.47%
Short Interest
Short Ratio4.0d
Short % Float6.91%
Short % Out.6.72%
Shares Short377.16K
Short (prev mo.)447.05K
Technical
SMA 50129.16 (+3.3%)
SMA 200106.77 (+25.0%)
Beta1.08
S&P 52W Chg12.08%
Avg Vol (30d)101.17K
Avg Vol (10d)127.48K
Technical Indicators
RSI (14)52.6
MACD2.2553
MACD Signal1.7228
MACD Hist.+0.5325
BB Upper141.94 USD
BB Middle130.96 USD
BB Lower119.98 USD
BB Width16.77%
ATR (14)5.759 USD
Vol Ratio (20d)0.94x

About Mesa Laboratories (NASDAQ: MLAB)

›

Mesa Laboratories (NASDAQ: MLAB) is listed on Nasdaq, where its shares trade in USD. It belongs to the Scientific & Technical Instruments industry, part of the Technology sector, and reports about 717 employees.

The shares were at 133.41 USD on 19 November 2026, up 78.8% over 52 weeks. Its 52-week range is 69.51 USD to 144.35 USD: the price is 7.6% below the high and 91.9% above the low.

At a market capitalisation of 749.83M USD, it trades at 115.0 times trailing earnings and 11.0 times forward earnings. The median trailing P/E of its 19 largest Scientific & Technical Instruments peers is 31.0, a premium of 271% for MLAB. It pays a dividend yielding 0.46% (it pays out 55% of its earnings), against a median of 1.05% among the dividend payers in that peer group.

Mesa Laboratories reports return on equity of 3.6%, an operating margin of 10.4% and revenue up 2.6% year over year.

Its debt exceeds its cash by 125.56M USD, a debt-to-equity ratio of 0.83. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. One analyst covers the stock, with an average rating of Buy; their mean price target of 150.00 USD is 12.4% above the current price. The next earnings report is expected on 3 February 2027.